Therefore, to confirm the role of OPG and its ligands, RANKL and TRAIL, in the pathophysiology of RA, we determined for the first time the differential gene expression of these molecules in peripheral blood from patients with RA, with and without IHD, and healthy controls. The gene discussed is TNFSF11; the disease is rheumatoid arthritis.